FDA Warning Letter — MOLLUSCUMRX
The FDA took a Warning Letter action against MOLLUSCUMRX on Aug 18, 2023 (Orlando, FL). The action was issued by CDER and concerns drugs products.
Action Details
- Facility
- MOLLUSCUMRX
- Date
- Aug 18, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Center
- CDER
- Location
- Orlando, FL (United States)